Tags

Type your tag names separated by a space and hit enter

Coronavirus diseases and pregnancy: COVID-19,SARS, and MERS.
Przegl Epidemiol. 2020; 74(2):276-289.PE

Abstract

Around the end of December 2019, a new beta-coronavirus from Wuhan City, Hubei Province, China began to spread rapidly. The new virus, called SARS-CoV-2, which could be transmitted through respiratory droplets, had a range of mild to severe symptoms, from simple cold in some cases to death in others. The disease caused by SARS-CoV-2 was named COVID-19 by WHO and has so far killed more people than SARS and MERS. Following the widespread global outbreak of COVID-19, with more than 132758 confirmed cases and 4955 deaths worldwide, the World Health Organization declared COVID-19 a pandemic disease in January 2020. Earlier studies on viral pneumonia epidemics has shown that pregnant women are at greater risk than others. During pregnancy, the pregnant woman is more prone to infectious diseases. Research on both SARS-CoV and MERS-CoV, which are pathologically similar to SARS-CoV-2, has shown that being infected with these viruses during pregnancy increases the risk of maternal death, stillbirth, intrauterine growth retardation and, preterm delivery. With the exponential increase in cases of COVID-19 throughout the world, there is a need to understand the effects of SARS-CoV-2 on the health of pregnant women, through extrapolation of earlier studies that have been conducted on pregnant women infected with SARS-CoV, and MERS-CoV. There is an urgent need to understand the chance of vertical transmission of SARS-CoV-2 from mother to fetus and the possibility of the virus crossing the placental barrier. Additionally, since some viral diseases and antiviral drugs may have a negative impact on the mother and fetus, in which case, pregnant women need special attention for the prevention, diagnosis, and treatment of COVID-19.

Authors+Show Affiliations

Student's Research committee, School of medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.Student's Research committee, School of medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.Student's Research committee, School of medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.Student's Research committee, School of medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.Student's Research committee, School of medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.Student research committee, Faculty of dentistry, Tehran Medical sciences, Islamic Azad university, Tehran, Iran.Royan Institute - Department of Endocrinology and Female Infertility,Reproductive Biomedicine, Research Center, ACECR, Tehran, Iran.Department of Microbiology, Faculty of Medicine, Shahid Beheshti University.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

33112124

Citation

Fathi, Mobina, et al. "Coronavirus Diseases and Pregnancy: COVID-19,SARS, and MERS." Przeglad Epidemiologiczny, vol. 74, no. 2, 2020, pp. 276-289.
Fathi M, Vakili K, Deravi N, et al. Coronavirus diseases and pregnancy: COVID-19,SARS, and MERS. Przegl Epidemiol. 2020;74(2):276-289.
Fathi, M., Vakili, K., Deravi, N., Yaghoobpoor, S., Ahsan, E., Mokhtari, M., Moshfeghi, M., & Vaezjalali, M. (2020). Coronavirus diseases and pregnancy: COVID-19,SARS, and MERS. Przeglad Epidemiologiczny, 74(2), 276-289. https://doi.org/10.32394/pe.74.21
Fathi M, et al. Coronavirus Diseases and Pregnancy: COVID-19,SARS, and MERS. Przegl Epidemiol. 2020;74(2):276-289. PubMed PMID: 33112124.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Coronavirus diseases and pregnancy: COVID-19,SARS, and MERS. AU - Fathi,Mobina, AU - Vakili,Kimia, AU - Deravi,Niloofar, AU - Yaghoobpoor,Shirin, AU - Ahsan,Elahe, AU - Mokhtari,Melika, AU - Moshfeghi,Maryam, AU - Vaezjalali,Maryam, PY - 2020/10/28/entrez PY - 2020/10/29/pubmed PY - 2020/11/11/medline KW - 2019 novel coronavirus KW - COVID-19 KW - SARS-CoV-2 KW - neonates KW - pregnancy SP - 276 EP - 289 JF - Przeglad epidemiologiczny JO - Przegl Epidemiol VL - 74 IS - 2 N2 - Around the end of December 2019, a new beta-coronavirus from Wuhan City, Hubei Province, China began to spread rapidly. The new virus, called SARS-CoV-2, which could be transmitted through respiratory droplets, had a range of mild to severe symptoms, from simple cold in some cases to death in others. The disease caused by SARS-CoV-2 was named COVID-19 by WHO and has so far killed more people than SARS and MERS. Following the widespread global outbreak of COVID-19, with more than 132758 confirmed cases and 4955 deaths worldwide, the World Health Organization declared COVID-19 a pandemic disease in January 2020. Earlier studies on viral pneumonia epidemics has shown that pregnant women are at greater risk than others. During pregnancy, the pregnant woman is more prone to infectious diseases. Research on both SARS-CoV and MERS-CoV, which are pathologically similar to SARS-CoV-2, has shown that being infected with these viruses during pregnancy increases the risk of maternal death, stillbirth, intrauterine growth retardation and, preterm delivery. With the exponential increase in cases of COVID-19 throughout the world, there is a need to understand the effects of SARS-CoV-2 on the health of pregnant women, through extrapolation of earlier studies that have been conducted on pregnant women infected with SARS-CoV, and MERS-CoV. There is an urgent need to understand the chance of vertical transmission of SARS-CoV-2 from mother to fetus and the possibility of the virus crossing the placental barrier. Additionally, since some viral diseases and antiviral drugs may have a negative impact on the mother and fetus, in which case, pregnant women need special attention for the prevention, diagnosis, and treatment of COVID-19. SN - 0033-2100 UR - https://www.unboundmedicine.com/medline/citation/33112124/Coronavirus_diseases_and_pregnancy:_COVID_19SARS_and_MERS_ L2 - http://www.diseaseinfosearch.org/result/5922 DB - PRIME DP - Unbound Medicine ER -